Compare Novartis AG (NVS) vs VICI Properties Inc (VICI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novartis AG vs VICI Properties Inc — how do they compare? Novartis AG trades at $153.88 (market cap $290.25B), while VICI Properties Inc trades at $26.59 (market cap $29.55B). The key difference: Novartis AG is far larger — about 9.8× VICI Properties Inc's market cap, and VICI Properties Inc pays the higher dividend (6.71%). Which is the better fit depends on your goals.
| NVS | VICI | |
|---|---|---|
Market Cap | $290.25B | $29.55B |
Sector | Health | Real Estate |
52-Week High | $168.62 | $33.93 |
52-Week Low | $113.50 | $25.94 |
Enterprise Value | $330.27B | $46.77B |
Dividend Yield | 3.17% | 6.71% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Novartis AG
Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →About VICI Properties Inc
VICI Properties is an S&P 500 experiential real estate investment trust (REIT) that owns one of the largest portfolios of market-leading gaming, hospitality, and entertainment destinations, including Caesars Palace and MGM Grand. It utilizes a long-term, triple-net lease model to provide stable, inflation-protected income, serving as the primary landlord for the 'experience economy' while diversifying into non-gaming sectors like wellness, youth sports, and luxury resorts.
Read more on VICI →
